Integer Promotes Payman Khales to President, CEO

Integer Holdings Corporation, a medical device contract development and manufacturing organization (CDMO), has appointed Payman Khales as its new president and CEO, as part of a planned transition originally announced in April.

Khales succeeds Joseph Dziedzic, who is retiring after eight years as Integer’s president and CEO. He will serve as an advisor through March 31, 2026 to support the transition.

Khales joined Integer in 2018 as president of the company’s Cardio & Vascular business, where he double sales in seven years. He was most recently chief operating officer and oversaw both of the company’s business units and its global operations.

Before joining Integer, Khales had senior leadership positions at CECO Environmental Corp. and Ingersoll Rand Company.

“It is a privilege to step into the role of CEO at Integer,” said Khales. “I am energized by the opportunities ahead as we continue to advance our strategy. Together with our talented associates, we will create value by innovating, collaborating with our customers, and delivering life-changing medical technologies to patients around the world. I am grateful to Joe for his mentorship and support, and I look forward to leading Integer.”

In May, the company hired Getinge and Boston Scientific veteran Tony Carr as its executive VP, quality assurance and regulatory affairs.